Loading...

Richard K Valicenti, MD; MA

Title(s)Professor, Radiation Oncology
SchoolUniversity of California, Davis
Address4501 X Street, Suite G140
CA 95817
Phone(916)502-3623
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical feasibility of MR-assisted CT-based cervical brachytherapy using MR-to-CT deformable image registration. Brachytherapy. 2020 Apr 20. Dyer BA, Yuan Z, Qiu J, Shi L, Wright C, Benedict SH, Valicenti R, Mayadev JS, Rong Y. PMID: 32327343.
      View in: PubMed   Mentions:    Fields:    
    2. VA-Radiation Oncology Quality Surveillance Program. Int J Radiat Oncol Biol Phys. 2020 03 01; 106(3):639-647. Hagan M, Kapoor R, Michalski J, Sandler H, Movsas B, Chetty I, Lally B, Rengan R, Robinson C, Rimner A, Simone C, Timmerman R, Zelefsky M, DeMarco J, Hamstra D, Lawton C, Potters L, Valicenti R, Mutic S, Bosch W, Abraham C, Caruthers D, Brame R, Palta JR, Sleeman W, Nalluri J. PMID: 31983560.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Pract Radiat Oncol. 2019 Dec 20. Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. PMID: 31866577.
      View in: PubMed   Mentions:    Fields:    
    4. Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study. Anticancer Res. 2019 Nov; 39(11):6373-6378. Buwenge M, Deodato F, Macchia G, Siepe G, Zhao X, Valicenti RK, Cilla S, Alitto AR, Ntreta M, Bisello S, Mantini G, Valentini V, Morganti AG, Cammelli S. PMID: 31704870.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018-2019. J Urol. 2019 09; 202(3):533-538. Pisansky TM, Thompson IM, Valicenti RK, D'Amico AV, Selvarajah S. PMID: 31042111.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018. Pract Radiat Oncol. 2019 Jul - Aug; 9(4):208-213. Pisansky TM, Thompson IM, Valicenti RK, D'Amico AV, Selvarajah S. PMID: 31051281.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Factors associated with deformation accuracy and modes of failure for MRI-optimized cervical brachytherapy using deformable image registration. Brachytherapy. 2019 May - Jun; 18(3):378-386. Dyer BA, Yuan Z, Qiu J, Benedict SH, Valicenti RK, Mayadev JS, Rong Y. PMID: 30745016.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California. Gynecol Oncol. 2018 07; 150(1):73-78. Mayadev J, Klapheke A, Yashar C, Hsu IC, Kamrava M, Mundt AJ, Mell LK, Einck J, Benedict S, Valicenti R, Cress R. PMID: 29709291.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1259-1270. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. PMID: 29891204.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    10. Smoking Decreases Survival in Locally Advanced Cervical Cancer Treated With Radiation. Am J Clin Oncol. 2018 03; 41(3):295-301. Mayadev J, Lim J, Durbin-Johnson B, Valicenti R, Alvarez E. PMID: 26808259.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Converting Treatment Plans From Helical Tomotherapy to L-Shape Linac: Clinical Workflow and Dosimetric Evaluation. Technol Cancer Res Treat. 2018 01 01; 17:1533033818785279. Yuan Z, Nair CK, Benedict SH, Valicenti RK, Rao S, Fragoso RC, Wright C, Qiu J, Rong Y. PMID: 29986638.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer. Technol Cancer Res Treat. 2018 01 01; 17:1533033818782788. Shi L, He Y, Yuan Z, Benedict S, Valicenti R, Qiu J, Rong Y. PMID: 29940810.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy. Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):695-701. Valicenti RK, Pugh SL, Trabulsi EJ, Sartor O, Ko EC, Girvigian MR, Rosenthal SA, Shaves ME, Hoffman-Censits JH, Schallenkamp J, Sandler HM. PMID: 29413282.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    14. Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer: An Opportunity of Lifestyle Intervention for Outcome Improvement. Am J Clin Oncol. 2017 Oct; 40(5):451-457. Mayadev J, Li CS, Lim J, Valicenti R, Alvarez EA. PMID: 25784565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Postoperative Radiation After Radical Prostatectomy. Semin Radiat Oncol. 2017 01; 27(1):50-66. Ko EC, Michaud AL, Valicenti RK. PMID: 27986212.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer. Brachytherapy. 2016 May-Jun; 15(3):333-340. Tait LM, Hoffman D, Benedict S, Valicenti R, Mayadev JS. PMID: 26882845.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):526-31. Sperduto PW, Shanley R, Luo X, Andrews D, Werner-Wasik M, Valicenti R, Bahary JP, Souhami L, Won M, Mehta M. PMID: 25304947.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    18. Utilization and impact of a postmastectomy radiation boost for invasive breast cancer. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):e269-78. Mayadev J, Fish K, Valicenti R, West D, Chen A, Martinez S, Phillips T. PMID: 25407878.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Implant time and process efficiency for CT-guided high-dose-rate brachytherapy for cervical cancer. Brachytherapy. 2014 May-Jun; 13(3):233-9. Mayadev J, Qi L, Lentz S, Benedict S, Courquin J, Dieterich S, Mathai M, Stern R, Valicenti R. PMID: 24559793.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Qual Life Res. 2014 Aug; 23(6):1841-58. Hoffman KE, Pugh SL, James JL, Scarantino C, Movsas B, Valicenti RK, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA. PMID: 24492945.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    21. Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):822-8. Valicenti RK, Thompson I, Albertsen P, Davis BJ, Goldenberg SL, Wolf JS, Sartor O, Klein E, Hahn C, Michalski J, Roach M, Faraday MM. PMID: 23845839.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    22. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 01; 87(2):317-22. Rash DL, Lee YC, Kashefi A, Durbin-Johnson B, Mathai M, Valicenti R, Mayadev JS. PMID: 23906933.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy. Int J Gynecol Cancer. 2013 Jul; 23(6):1078-83. Lim J, Durbin-Johnson B, Valicenti R, Mathai M, Stern RL, Mayadev J. PMID: 23792603.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. The impact of body mass index on rectal dose in locally advanced cervical cancer treated with high-dose-rate brachytherapy. Brachytherapy. 2013 Nov-Dec; 12(6):550-4. Lim J, Durbin-Johnson B, Valicenti R, Mathai M, Stern RL, Mayadev J. PMID: 23706512.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol. 2013 Aug; 190(2):441-9. Thompson IM, Valicenti RK, Albertsen P, Davis BJ, Goldenberg SL, Hahn C, Klein E, Michalski J, Roach M, Sartor O, Wolf JS, Faraday MM. PMID: 23707439.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    26. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer. 2013 May; 23(4):615-21. Kunos CA, Winter K, Dicker AP, Small W, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK. PMID: 23552804.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Interfraction motion of the vaginal apex during postoperative intensity modulated radiation therapy: are we missing the target? Int J Gynecol Cancer. 2013 Feb; 23(2):385-92. Rash D, Hagar Y, Cui J, Hunt JP, Valicenti R, Mayadev J. PMID: 23287959.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e363-70. Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, Parliament M, Purdy JA, Valicenti RK, Cox JD. PMID: 22633552.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    29. Radiation treatment for patients with intermediate-risk prostate cancer. Ther Adv Urol. 2012 Jun; 4(3):113-24. Greene DE, Mayadev JS, Valicenti RK. PMID: 22654963.
      View in: PubMed   Mentions:
    30. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1324-9. Perks JR, Stanic S, Stern RL, Henk B, Nelson MS, Harse RD, Mathai M, Purdy JA, Valicenti RK, Siefkin AD, Chen AM. PMID: 22197236.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    31. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):1897-902. Stanic S, Mathai M, Cui J, Purdy JA, Valicenti RK. PMID: 21536391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1323-9. Valicenti RK, Bae K, Michalski J, Sandler H, Shipley W, Lin A, Cox J. PMID: 21414514.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    33. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract. 2010 Nov; 6(6):e5-e10. Gomella LG, Lin J, Hoffman-Censits J, Dugan P, Guiles F, Lallas CD, Singh J, McCue P, Showalter T, Valicenti RK, Dicker A, Trabulsi EJ. PMID: 21358951.
      View in: PubMed   Mentions: 19     Fields:    
    34. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate. 2011 May; 71(6):567-74. Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, White Rde V. PMID: 20878953.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    35. Reply by the Authors. Urology. 2010 Sep 1; 76(3):768-769. Robert A. Linden, Perry R. Weiner, Leonard G. Gomella, Edouard J. Trabulsi, Adam P. Dicker, David B. Suh, Richard K. Valicenti. .
      View in: Publisher Site   Mentions:
    36. Vector analysis of prostate patient setup with image-guided radiation therapy via kV cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):915-9. Perks J, Turnbull H, Liu T, Purdy J, Valicenti R. PMID: 20643510.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. A Phase I trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: first report of a completed study. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):732-7. Valicenti RK, Trabulsi E, Intenzo C, Lavarino J, Xu Y, Chervoneva I. PMID: 20399029.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    38. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):14-22. Michalski JM, Bae K, Roach M, Markoe AM, Sandler HM, Ryu J, Parliament MB, Straube W, Valicenti RK, Cox JD. PMID: 19577865.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    39. Time of decline in sexual function after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):31-5. Siglin J, Kubicek GJ, Leiby B, Valicenti RK. PMID: 19395191.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    40. Reply. Urology. 2009 Jun 1; 73(6):1334-1335. Mark L. Pe, Edouard J. Trabulsi, Richard K. Valicenti. .
      View in: Publisher Site   Mentions:
    41. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):361-8. Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C. PMID: 19394158.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    42. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT. Urology. 2009 Jun; 73(6):1328-34. Pe ML, Trabulsi EJ, Kedika R, Pequignot E, Dicker AP, Gomella LG, Valicenti RK. PMID: 19376564.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy. Urology. 2009 Apr; 73(4):881-6. Linden RA, Weiner PR, Gomella LG, Dicker AP, Suh DB, Trabulsi EJ, Valicenti RK. PMID: 19193411.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Reply. Urology. 2008 Dec 1; 72(6):1303. Edouard J. Trabulsi, Richard K. Valicenti. .
      View in: Publisher Site   Mentions:
    45. Reply. Urology. 2008 Dec 1; 72(6):1304. Edouard J. Trabulsi, Richard K. Valicenti. .
      View in: Publisher Site   Mentions:
    46. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Jun 01; 74(2):377-82. Lawton CA, Michalski J, El-Naqa I, Kuban D, Lee WR, Rosenthal SA, Zietman A, Sandler H, Shipley W, Ritter M, Valicenti R, Catton C, Roach M, Pisansky TM, Seider M. PMID: 18947941.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    47. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology. 2008 Dec; 72(6):1298-302; discussion 1302-4. Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin LL, DeWeese TL, Scardino PT, Stephenson AJ, Pollack A. PMID: 18672274.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    48. Editorial Comment. The Journal of Urology. 2008 Jun 1; 179(6):2185-2186. Robert B. Den, Richard K. Valicenti. .
      View in: Publisher Site   Mentions:
    49. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. J Clin Oncol. 2008 Feb 01; 26(4):585-91. Roach M, Bae K, Speight J, Wolkov HB, Rubin P, Lee RJ, Lawton C, Valicenti R, Grignon D, Pilepich MV. PMID: 18172188.
      View in: PubMed   Mentions: 143     Fields:    Translation:HumansCTClinical Trials
    50. A cone beam CT-Based Study for Clinical Target Definition Using Pelvic Anatomy During Postprostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Feb 01; 70(2):431-6. Showalter TN, Nawaz AO, Xiao Y, Galvin JM, Valicenti RK. PMID: 17869021.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    51. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys. 2007 Nov 01; 69(3):646-55. Lawton CA, DeSilvio M, Roach M, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR. PMID: 17531401.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    52. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007 May 20; 25(15):2035-41. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A. PMID: 17513807.
      View in: PubMed   Mentions: 195     Fields:    Translation:Humans
    53. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1417-23. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, DeWeese TL, Sandler HM. PMID: 17418972.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    54. Advanced prostate cancer and postoperative radiotherapy. JAMA. 2007 Mar 07; 297(9):950-1; author reply 951. Pisansky TM, Pollack A, Sandler HM, Valicenti RK. PMID: 17341706.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):647-53. Roach M, DeSilvio M, Valicenti R, Grignon D, Asbell SO, Lawton C, Thomas CR, Shipley WU. PMID: 17011443.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    56. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1064-71. Valicenti RK, DeSilvio M, Hanks GE, Porter A, Brereton H, Rosenthal SA, Shipley WU, Sandler HM. PMID: 16979837.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    57. Dose escalation with proton-beam boost for low-risk prostate cancer. Nat Clin Pract Urol. 2006 May; 3(5):256-7. Trabulsi EJ, Valicenti RK. PMID: 16691237.
      View in: PubMed   Mentions:    Fields:    
    58. Chapter 27 Regionally Advanced Adenocarcinoma of the Prostate (T3-4N+M0): Management and Prognosis. . 2005 Jan 1; 494-504. Mary Frances McAleer, Richard K. Valicenti. .
      View in: Publisher Site   Mentions:
    59. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Dec 01; 60(5):1357-63. Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E. PMID: 15590165.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    60. Combining external beam radiotherapy with prostate brachytherapy: issues and rationale. Urology. 2004 Nov; 64(5):855-61. Febles C, Valicenti RK. PMID: 15533463.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology. 2004 Jul; 64(1):84-9. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. PMID: 15245941.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    62. Inverse treatment planning using volume-based objective functions. Phys Med Biol. 2004 Jun 21; 49(12):2503-14. Bednarz G, Michalski D, Anne PR, Valicenti RK. PMID: 15272670.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    63. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1093-7. Valicenti RK, Chervoneva I, Gomella LG. PMID: 15001249.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):735-42. Michalski JM, Winter K, Purdy JA, Perez CA, Ryu JK, Parliament MB, Valicenti RK, Roach M, Sandler HM, Markoe AM, Cox JD. PMID: 14967428.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    65. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer. Urology. 2003 Dec 29; 62 Suppl 1:46-54. Gomella LG, Zeltser I, Valicenti RK. PMID: 14747041.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):614-20. Valicenti RK, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J. PMID: 14529764.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    67. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol. 2003 May 15; 21(10):1904-11. Roach M, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti RK, Han S, Thomas CR, Shipley WS. PMID: 12743142.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansCTClinical Trials
    68. Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol. 2003 Apr; 13(2):130-40. Valicenti RK, Gomella LG, Perez CA. PMID: 12728442.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Chapter 41 Is One Form of Radiation Therapy Better Over Another?. . 2003 Jan 1; (Cancer851999):387-390. Richard K. Valicenti. .
      View in: Publisher Site   Mentions:
    70. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol. 2002 Dec; 168(6):2499-504; discussion 2504. Valicenti RK, Bissonette EA, Chen C, Theodorescu D. PMID: 12441949.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. The management of locally advanced prostate cancer. Prostate Cancer Prostatic Dis. 2002; 5 Suppl 2:S8-11. Valicenti RK. PMID: 12496990.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer? Int J Radiat Oncol Biol Phys. 2001 Jul 01; 50(3):591-5. Chen CT, Valicenti RK, Lu J, Derose T, Dicker AP, Strup SE, Mulholland SG, Hirsch IH, McGinnis DE, Gomella LG. PMID: 11395224.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    73. Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy. Urology. 2001 Apr; 57(4):769-73. Valicenti RK, Choi E, Chen C, Lu JD, Hirsch IH, Mulholland GS, Gomella LG. PMID: 11306401.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    74. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy. Int J Cancer. 2001; 96 Suppl:83-8. Chen CT, Waterman FM, Valicenti RK, Gomella LG, Strup SE, Dicker AP. PMID: 11992390.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. An optimized forward-planning technique for intensity modulated radiation therapy. Med Phys. 2000 Sep; 27(9):2093-9. Xiao Y, Galvin J, Hossain M, Valicenti R. PMID: 11011738.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol. 2000 Aug; 18(3):188-91. Valicenti RK, Gomella LG, El-Gabry EA, Myers R, Nathan F, Strup S, Dicker A, McGinnis DE, Cardi G, Baltish M, Simirgliano M, Vizzard A, Mulholland SG. PMID: 10975490.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol. 2000 Jul; 18(14):2740-6. Valicenti R, Lu J, Pilepich M, Asbell S, Grignon D. PMID: 10894874.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    78. Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Tech Urol. 2000 Jun; 6(2):104-8. Dicker AP, Figura AT, Waterman FM, Valicenti RK, Strup SE, Gomella LG. PMID: 10798809.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Durable efficacy of adjuvant radiation therapy for prostate cancer: will the benefit last? Semin Urol Oncol. 2000 May; 18(2):115-20. Valicenti RK, Gomella LG. PMID: 10875451.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Changes in the size and location of kidneys from the supine to standing positions and the implications for block placement during total body irradiation. Int J Radiat Oncol Biol Phys. 1999 Sep 01; 45(2):447-9. Reiff JE, Werner-Wasik M, Valicenti RK, Huq MS. PMID: 10487569.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    81. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 1999 Aug 01; 45(1):53-8. Valicenti RK, Gomella LG, Ismail M, Strup SE, Mulholland SG, Dicker AP, Petersen RO, Newschaffer CJ. PMID: 10477006.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    82. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1999 Jul 01; 44(4):931-5. Valicenti RK, Sweet JW, Hauck WW, Hudes RS, Lee T, Dicker AP, Waterman FM, Anne PR, Corn BW, Galvin JM. PMID: 10386652.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    83. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology. 1998 Dec; 52(6):1034-40. Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Strup S, Petersen RO, Corn BW, Lu JD. PMID: 9836551.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    84. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):501-6. Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW. PMID: 9806507.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    85. Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control. Cancer. 1998 May 15; 82(10):1909-14. Valicenti RK, Gomella LG, Ismail M, Mullholland SG, Petersen RO, Corn BW. PMID: 9587124.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    86. Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy. Urology. 1998 May; 51(5):782-7. Corn BW, Valicenti RK, Mulholland SG, Hyslop T, Gomella L. PMID: 9610592.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    87. Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report. Am J Clin Oncol. 1998 Feb; 21(1):31-5. Corn BW, Micaily B, Dunton CJ, Heller P, Valicenti RK, Anderson L, Hernandez E. PMID: 9499253.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    88. A prospective, randomized study addressing the need for physical simulation following virtual simulation. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):1131-5. Valicenti RK, Waterman FM, Corn BW, Curran WJ. PMID: 9392555.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    89. National trends in the surgical staging of corpus cancer: a pattern-of-practice survey. Obstet Gynecol. 1997 Oct; 90(4 Pt 1):628-31. Corn BW, Dunton CJ, Carlson JA, Xie Y, Valicenti RK. PMID: 9380328.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    90. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol. 1997 Sep; 158(3 Pt 1):746-9. DiBiase SJ, Valicenti RK, Schultz D, Xie Y, Gomella LG, Corn BW. PMID: 9258072.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    91. Efficient CT simulation of the four-field technique for conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1997 Mar 01; 37(4):953-7. Valicenti RK, Waterman FM, Croce RJ, Corn B, Suntharalingam N, Curran WJ. PMID: 9128974.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    92. Prospective clinical evaluation of an electronic portal imaging device. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):943-51. Michalski JM, Graham MV, Bosch WR, Wong J, Gerber RL, Cheng A, Tinger A, Valicenti RK. PMID: 8598374.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    93. An analysis of intratreatment and intertreatment displacements in pelvic radiotherapy using electronic portal imaging. Int J Radiat Oncol Biol Phys. 1996 Feb 01; 34(3):683-90. Tinger A, Michalski JM, Bosch WR, Valicenti RK, Low DA, Myerson RJ. PMID: 8621293.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    94. Quantitative verification of 192Ir PDR and HDR source structure by pin-hole autoradiography. Med Phys. 1995 Nov; 22(11 Pt 1):1753-7. Kirov AS, Meigooni AS, Zhu Y, Valicenti RK, Williamson JF. PMID: 8587529.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Experimental validation of Monte Carlo dose calculations about a high-intensity Ir-192 source for pulsed dose-rate brachytherapy. Med Phys. 1995 Jun; 22(6):821-9. Valicenti RK, Kirov AS, Meigooni AS, Mishra V, Das RK, Williamson JF. PMID: 7565373.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Is weekly port filming adequate for verifying patient position in modern radiation therapy? Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):431-8. Valicenti RK, Michalski JM, Bosch WR, Gerber R, Graham MV, Cheng A, Purdy JA, Perez CA. PMID: 7928470.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    97. Non-Hodgkin lymphoma: whole-abdomen irradiation as an adjuvant to chemotherapy. Radiology. 1994 Aug; 192(2):571-6. Valicenti RK, Wasserman TH, Monyak DJ, Kucik NA. PMID: 8029434.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    98. Intracavitary brachytherapy for squamous cell carcinoma of the esophagus. Am J Clin Oncol. 1994 Apr; 17(2):170-4. Micaily B, Miyamoto C, Valicenti RK, Brady LW. PMID: 8141111.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    99. An evaluation of two methods of anatomical alignment of radiotherapy portal images. Int J Radiat Oncol Biol Phys. 1993 Dec 01; 27(5):1199-206. Michalski JM, Wong JW, Bosch WR, Yan D, Cheng A, Gerber RL, Graham MV, Low D, Valicenti RK, Piephoff JV. PMID: 8262848.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    100. Analysis of prognostic factors in localized gastric lymphoma: the importance of bulk of disease. Int J Radiat Oncol Biol Phys. 1993 Oct 20; 27(3):591-8. Valicenti RK, Wasserman TH, Kucik NA. PMID: 8226153.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Richard K's Networks
    Concepts (313)
    Derived automatically from this person's publications.
    _
    Co-Authors (36)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _